AFT-Leflunomide

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Leflunomide 10mg;  

Commercializzato da:

AFT Pharmaceuticals Ltd

INN (Nome Internazionale):

Leflunomide 10 mg

Dosaggio:

10 mg

Forma farmaceutica:

Film coated tablet

Composizione:

Active: Leflunomide 10mg   Excipient: Colloidal silicon dioxide Crospovidone Lactose monohydrate Maize starch Opadry white 85F18378 Povidone Purified talc

Confezione:

Bottle, plastic, HDPE with PP screw cap, 30 tablets, 30 tablets

Classe:

Prescription

Tipo di ricetta:

Prescription

Prodotto da:

Assia Chemical Industries Ltd

Indicazioni terapeutiche:

AFT-LEFLUNOMIDE is indicated for treating rheumatoid arthritis, for improving signs and symptoms of the disease, for retarding joint destruction and also for improving functionality and the quality of life. AFT-LEFLUNOMIDE can be used with patients who have not responded to alternative treatments or as a first line treatment in patients who have a contraindication to other medicines.

Dettagli prodotto:

Package - Contents - Shelf Life: Bottle, plastic, HDPE with PP screw cap, 30 tablets - 30 tablets - 24 months from date of manufacture stored at or below 25°C protect from light - Bottle, plastic, HDPE with PP screw cap, 100 tablets - 100 tablets - 24 months from date of manufacture stored at or below 25°C protect from light

Data dell'autorizzazione:

2005-09-20